Genmab — Oktober 2023
-
Hvis det holder stik, at afgørelsen af voldgiftsanken skal ske ultimo oktober, bliver det vel den kommende nat, at den foreligger.
-
Genmab har tabt sagen 2 gange. Nu er det tredje gang, og ja - de har argumenter nu, men alle regner seriøst med at sagen tabes igen. Det ER og bliver det ventede udfald. Alligevel vil vi temmelig sikkert se et mindre dyk, som efterfølgende samles op igen. Men personligt er jeg så meget optimist, at jeg selv tilslutter mig SB’s 33% chance. Men igen - allertungeste spillere har afskrevet det og regner med et tab. Min vinkel. Vinder de vil vi se en markant stigning. Så alt i alt, ingen bekymring
-
AbbVie Raises 2023 Adj. EPS Guidance; Announces 2024 Dividend Increase https://www.proinvestor.com/investornyt/1070014/abbvie-raises-2023-adj-eps-guidance-announces-2024-dividend-increase
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
